News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Veloxis Pharmaceuticals A/S Release: Major Shareholder Announcements
November 13, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Hørsholm, Denmark, 13 November 2012 -- Pursuant to section 29 of the Danish Securities Trading Act, Veloxis Pharmaceuticals A/S (OMX: VELO) hereby makes public, that the company has received the following major shareholder announcements:
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Insights
Fragile X at a turning point: Breaking through the clinical bottleneck
August 27, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Insights
Rewriting the rules of CMV prevention
August 20, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
7 biopharma M&A deals where layoffs followed
August 20, 2026
·
5 min read
·
Angela Gabriel
Insights
Italian biotech gains momentum as VC funding, tech transfer environment improve
August 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker